跳到正文

DAILY PAPER READING

每日文献解读

每天一篇,讲清研究问题、方法、结果与证据边界。

2026-11-13 · 原文发表于 2018-10-03

噬菌体鸡尾酒对比标准治疗烧伤感染:所给摘要未提供结果

Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J.. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. The Lancet. Infectious diseases. 2019;19(1):35-45. doi:10.1016/s1473-3099(18)30482-1. PMID:30292481.

查看原始文献(Europe PMC · 创面修复近十年核心候选归档)↗

研究问题

对于铜绿假单胞菌感染的烧伤创面,12种裂解性抗铜绿假单胞菌噬菌体组成的鸡尾酒(PP1131)与标准治疗相比,疗效和耐受性如何?

作者报告,创面感染是烧伤患者发生脓毒症的主要原因,并增加烧伤相关的发病率和死亡率。噬菌体是天然的细菌病毒,正被考虑作为治疗多重耐药菌感染的替代疗法。摘要未说明除此之外的已有临床证据。

研究设计

这是一项随机1/2期试验,在法国和比利时的9个烧伤中心招募患者。纳入对象为年龄18岁及以上、烧伤创面经临床确认感染铜绿假单胞菌的患者。受试者通过交互式网络应答系统按1:1随机分配,接受每日外用治疗7天,随访14天:试验组为PP1131(1×10⁶噬菌斑形成单位/毫升),对照组为标准治疗(1%磺胺嘧啶银乳膏)。因两种治疗外观不同(标准治疗为厚膏体,PP1131为经敷料涂抹的透明液体),临床医生无法设盲;但分析样本的微生物学家和患者设盲,治疗在患者全身麻醉下实施。主要终点为细菌负荷持续降低至少两个象限的中位时间,采用四象限法,通过每日拭子评估,分析人群为第0天有微生物学记录感染且至少接受一次治疗的改良意向治疗人群;安全性在至少接受一次敷料的受试者中评估。摘要未说明样本量、随机化分层等细节,辅助研究部分在“评估”处截断,其目的摘要未说明。

主要发现

所提供的摘要文本仅包含背景和方法部分,并在辅助研究一句中途截断,未报告主要终点结果,也未报告细菌负荷的具体数值、组间比较、耐受性或安全性事件。因此,摘要未说明噬菌体组与标准治疗组在细菌负荷下降速度、疗效或耐受性方面的任何结果。

如何理解

仅凭所给摘要无法判断PP1131是否有效、是否优于或不劣于标准治疗,也不能据此证明其耐受性。研究设计本身不能代替结果;主要终点定义清晰,但没有结果数据就不能得出疗效结论。这提示需要查阅完整论文的结果部分才能进一步理解。

局限与不确定性

摘要明确写出的一项限制是临床医生无法设盲,可能影响治疗实施和临床判断。同时,仅凭摘要无法判断的关键项目包括:样本量、实际入组与完成情况、主要终点结果、统计学不确定性、安全性事件、随访完整性以及辅助研究的具体内容;这些均摘要未说明,不能把缺失信息写成作者承认的限制。

一句话带走

这是一项比较噬菌体鸡尾酒与磺胺嘧啶银标准治疗的烧伤感染随机1/2期试验,但所给摘要未提供结果,因此不能据此得出疗效或耐受性结论,需以完整论文为准;不作个体诊疗建议。

术语小注

噬菌体:
能感染并裂解细菌的天然病毒,本研究用其靶向铜绿假单胞菌。
铜绿假单胞菌:
一种可引起烧伤创面感染的细菌,常与耐药问题相关。
噬菌斑形成单位(PFU):
衡量有活性噬菌体数量的单位,本研究PP1131浓度为每毫升1×10⁶ PFU。
标准治疗:
本研究对照组使用的常规治疗,即1%磺胺嘧啶银乳膏。
改良意向治疗人群:
本研究的主要分析人群,指第0天有微生物学记录感染且至少接受一次治疗的受试者。
四象限法:
摘要提到的评估方法,用于判断细菌负荷是否持续降低至少两个象限;具体操作细节摘要未说明。
展开原文摘要

Background Wound infections are the main cause of sepsis in patients with burns and increase burn-related morbidity and mortality. Bacteriophages, natural bacterial viruses, are being considered as an alternative therapy to treat infections caused by multidrug-resistant bacteria. We aimed to compare the efficacy and tolerability of a cocktail of lytic anti-Pseudomonas aeruginosa bacteriophages with standard of care for patients with burns. Methods In this randomised phase 1/2 trial, patients with a confirmed burn wound infection were recruited from nine burn centres in hospitals in France and Belgium. Patients were eligible if they were aged 18 years or older and had a burn wound clinically infected with P aeruginosa. Eligible participants were randomly assigned (1:1) by use of an interactive web response system to a cocktail of 12 natural lytic anti-P aeruginosa bacteriophages (PP1131; 1 × 10 6 plaque-forming units [PFU] per mL) or standard of care (1% sulfadiazine silver emulsion cream), both given as a daily topical treatment for 7 days, with 14 days of follow-up. Masking of treatment from clinicians was not possible because of the appearance of the two treatments (standard of care a thick cream, PP1131 a clear liquid applied via a dressing), but assignments were masked from microbiologists who analysed the samples and patients (treatment applied while patients were under general anaesthetic). The primary endpoint was median time to sustained reduction in bacterial burden by at least two quadrants via a four-quadrant method, assessed by use of daily swabs in all participants with a microbiologically documented infection at day 0 who were given at least one sulfadiazine silver or phage dressing (modified intention-to-treat population). Safety was assessed in all participants who received at least one dressing according to protocol. Ancillary studies were done in the per-protocol population (all PP1131 participants who completed 7 days of treatment) to assess the r

本站中文摘要:这项在法国和比利时9家烧伤中心开展的随机Ⅰ/Ⅱ期试验,比较了12种裂解性抗铜绿假单胞菌噬菌体鸡尾酒PP1131与1%磺胺嘧啶银乳膏,二者均每日局部治疗7天并随访14天。

本文为 AI 辅助的学术文献解读,不替代原始研究、临床指南或专业医疗判断。请以原文为准。

创面修复研究前沿 · 学术交流用途,不提供诊断或个体治疗建议。